(19)
(11) EP 3 714 788 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
14.06.2023 Bulletin 2023/24

(45) Mention of the grant of the patent:
25.01.2023 Bulletin 2023/04

(21) Application number: 20154429.3

(22) Date of filing: 26.02.2010
(51) International Patent Classification (IPC): 
A61B 5/145(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/14532; A61B 5/1486; A61B 2560/0223; A61B 5/14865; A61B 2562/125; G01N 27/3272; A61B 5/1495

(54)

METHOD OF MAKING IMPROVED ANALYTE SENSORS

VERFAHREN ZUR HERSTELLUNG VON VERBESSERTEN ANALYTSENSOREN

PROCÉDÉ DE FABRICATION DE CAPTEURS D'ANALYTE AMÉLIORÉS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 26.02.2009 US 15588909 P
26.02.2009 US 15589109 P
26.02.2009 US 15589309 P
31.03.2009 US 16549909 P
31.08.2009 US 23846109 P
29.12.2009 US 29084709 P

(43) Date of publication of application:
30.09.2020 Bulletin 2020/40

(60) Divisional application:
21184415.4 / 3912551

(62) Application number of the earlier application in accordance with Art. 76 EPC:
10746954.6 / 2400886

(73) Proprietor: Abbott Diabetes Care, Inc.
Alameda, CA 94502 (US)

(72) Inventors:
  • THOMAS, Christopher, Allen
    San Leandro, CA California 94579 (US)
  • HOSS, Udo
    San Ramon, CA 94583 (US)
  • MCGARRAUGH, Geoffrey
    Oakland, CA California 94611 (US)
  • HAYTER, Gary, Alan
    Oakland, CA California 94618 (US)

(74) Representative: Booth, Catherine Louise 
Mathys & Squire The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)


(56) References cited: : 
WO-A1-94/20602
US-A1- 2005 211 572
US-A1- 2007 007 133
 US-A1- 2004 106 857
US-A1- 2006 183 178
US-A1- 2008 319 295
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).